Daniel Wollin, MD
Urology · West Roxbury, MANPI 1629360714
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $58,181 of the $62,074 with a category attached, or 93.7%. Boston Scientific accounts for 91.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $21,013 and has fallen 62.5% since, to $7,889 in 2025. Among urology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $721.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$56K
- Ambu A/s$2K
- Olympus Medical Systems Corporation$2K
- Olympus Corporation Of The Americas$766
- BD$419
- Calyxo, Inc.$164
- plus $213 from 2 others
What the payments were for
- Consulting fees$58,18194%
- Speaking & faculty fees$8001%
- Travel & lodging$1,3882%
- Food & beverage$1,7053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 65 | $56,476 |
| Ambu A/s | 2 | $2,416 |
| Olympus Medical Systems Corporation | 1 | $1,620 |
| Olympus Corporation Of The Americas | 10 | $766 |
| BD | 2 | $419 |
| Calyxo, Inc. | 3 | $164 |
| Richard Wolf Medical Instruments Corp. | 1 | $146 |
| Ambu Inc. | 2 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$26,865
- Moses$3,510
- GENERAL - THERAPIES$3,136
- Moses 550 D\F\L$3,000
- OES CHOLEDOCHOFIBERSCOPE$1,620
- PK SuperPulse$596
- ShockPulse - SE$596
- LithoVue$225
- ARISTA$214
- Surgiphor$205
- CVAC Aspiration System$138
How this compares
$62,074 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 57 | $34,967 |
| GemtesaVibegron | 20 | $16,315 |
| Potassium Citrate ErPotassium Citrate | 33 | $4,024 |
| Tamsulosin Hcl | 187 | $2,186 |
| Finasteride | 120 | $1,529 |
| Trospium Chloride | 27 | $1,081 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $499 |
| Cefpodoxime Proxetil | 11 | $397 |
| Allopurinol | 14 | $106 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $78 |
| Ciprofloxacin Hcl | 23 | $72 |
Paid to pharmacies, not to this prescriber.
Other urology in West Roxbury
- Christopher CutieBoston$3.5M
- Brian EisnerBoston$424K
- David StaskinBrighton$407K
- Liam HurleyNorth Andover$319K
- Stephen DretlerBoston$298K
- Abraham MorgentalerChestnut Hill$290K
- Louis LiouCambridge$278K
- Tony LuongoBoston$265K
- Ricardo MunarrizBoston$118K
- Andrew KramerHyannis$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.